InsiderTape plots every Form 4 on the price chart and flags cluster buys, CEO conviction, and first buys in years the moment they file. Start a free 7-day trial, cancel anytime.
START FREE TRIAL →Kevin Joseph Fitzgerald, a CSO & EVP, Head of Research, is a corporate insider tracked by InsiderTape across 1 company. The public record shows 20 open-market SEC Form 4 transactions: 0 purchases worth $0 and 20 sales worth $9.9M, reported from Jun 25, 24 to Mar 5, 26. Over this period they have been a net seller.
| Date | Company | Type | Shares | Price | Value |
|---|---|---|---|---|---|
| Mar 5, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 233 | $326.24 | $75K |
| Mar 4, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 210 | $325.67 | $68K |
| Mar 3, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 722 | $321.58 | $231K |
| Mar 2, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 392 | $332.64 | $128K |
| Feb 17, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 2.0K | $331.96 | $678K |
| Feb 13, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 2.0K | $310.08 | $607K |
| Jan 13, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 644 | $374.33 | $238K |
| Jan 12, 26 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 220 | $377.82 | $80K |
| Nov 17, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 8.2K | $463.08 | $3.7M |
| Oct 2, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 555 | $457.64 | $251K |
| Aug 18, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 543 | $455.82 | $247K |
| Mar 4, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 328 | $242.93 | $79K |
| Mar 3, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 487 | $248.36 | $119K |
| Feb 28, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 187 | $244.11 | $45K |
| Feb 18, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 1.1K | $259.10 | $272K |
| Feb 14, 25 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 164 | $264.87 | $42K |
| Nov 27, 24 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 851 | $254.48 | $214K |
| Nov 26, 24 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 826 | $252.27 | $208K |
| Aug 12, 24 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 9.7K | $274.65 | $2.6M |
| Jun 25, 24 | ALNYALNYLAM PHARMACEUTICALS, INC. | SELL | 227 | $235.19 | $52K |